Decitabine Natdecita 50 mg Injection

Description

Introduction Of Decitabine Natdecita 50mg Injection:

Decitabine Natdecita 50mg Injection contains Decitabine, a hypomethylating agent used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Decitabine Natdecita 50mg Injection is administered only by a trained healthcare professional through intravenous infusion, usually given in cycles over several days, repeated every 4 to 6 weeks. Your doctor will decide the dose and number of cycles based on your condition and response to treatment. It should never be self-administered.

Low blood cell counts are among the most common effects of this medicine, as it primarily affects rapidly dividing cells including those in the bone marrow. Your doctor may advise regular blood tests to monitor your blood counts and liver function during treatment. Inform your doctor if you experience fever, unusual bruising, bleeding, or signs of infection.

Uses Of Decitabine Natdecita 50mg Injection:

• Myelodysplastic Syndromes (MDS)
• Acute Myeloid Leukemia (AML)

Benefits Of Decitabine Natdecita 50mg Injection:

1. Myelodysplastic Syndromes (MDS)

MDS is a group of disorders where the bone marrow produces poorly formed or dysfunctional blood cells. Decitabine Natdecita 50mg Injection helps restore normal cell function in the bone marrow, improving blood cell production and helping manage the disease.

2. Acute Myeloid Leukemia (AML)

AML is a fast-growing cancer of the blood and bone marrow characterized by abnormal white blood cells. Decitabine Natdecita 50mg Injection helps control the growth of these abnormal cells, particularly in patients who may not be candidates for more intensive chemotherapy.

Side effects of Decitabine Natdecita 50mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Decitabine:

• Nausea
• Vomiting
• Fatigue
• Fever
• Diarrhea
• Low blood cell counts (anemia, neutropenia, thrombocytopenia)
• Injection site reactions
• Headache

Mechanism Of Action Of Decitabine Natdecita 50mg Injection:

Natdecita Injection contains Decitabine, a hypomethylating agent. It gets incorporated into the DNA of rapidly dividing cells and inhibits an enzyme called DNA methyltransferase. This reduces abnormal DNA methylation, helping reactivate genes that control normal cell growth and differentiation, which promotes the death of abnormal cells and supports normal blood cell production.

Contact Us